Gilead Sciences Chief Financial Officer Dickinson Andrew D sold 3,000 shares at $145.29 per share on September 15, 2026, under SEC transaction code S. The sale represented about 1.8% of his prior share holding, while his reported post-transaction position stood at 164,096 shares.
Key Highlights
- The transaction occurred on September 15, 2026, under SEC transaction code S.
- Dickinson Andrew D reported ownership of 164,096 Gilead Sciences shares after the transaction.
- The sale represented about 1.8% of his prior share holding.
Gilead Sciences (NASDAQ: GILD) Chief Financial Officer Dickinson Andrew D sold 3,000 shares at $145.29 per share. The transaction was completed on September 15, 2026, and involved a reported insider sale of Gilead Sciences stock. The transaction record identifies Dickinson Andrew D as Gilead Sciences' Chief Financial Officer. The reported price was $145.29 per share, with the sale involving 3,000 shares. The record identifies the seller by name and describes the transaction as involving Gilead Sciences shares.
Sale Represented 1.8% of Prior Holding
The sale represented about 1.8% of Dickinson's prior share holding. His reported ownership after the transaction was 164,096 shares. The stated percentage measures the transaction against the insider's own prior position in Gilead Sciences. The post-transaction ownership figure applies after the sale.
FAQs
Q: What did Dickinson Andrew D sell in Gilead Sciences?
A: Dickinson Andrew D sold 3,000 Gilead Sciences shares at $145.29 per share on September 15, 2026.
Q: How many Gilead Sciences shares did Dickinson Andrew D own afterward?
A: Dickinson Andrew D reported owning 164,096 Gilead Sciences shares after the transaction. The sale represented about 1.8% of his prior share holding.
Q: What does SEC transaction code S mean for the Gilead Sciences sale?
A: SEC transaction code S denotes an open-market sale in the insider transaction record. The reported transaction involved Gilead Sciences shares sold by Dickinson Andrew D.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.